chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the first vaccine, about a week later I noticed liquid on my night gown in the morning. And it?s always around the same time, 10 minutes after I wake up in the morning. It?s this little clear liquid on my night gown and I would see that every morning. And that continued for about a week after the vaccine and I didn?t connect it at the time. And it went away. I had the 2nd vaccine and a week later it started again and I was worried because breast cancer is in my family. I called my doctor and  she ordered a mammogram and a sonogram. I think within a week I had that done. They didn?t find anything. She wasn?t really worried about it and said it was weird. It was the tech at the mammogram place that said it might be in relation to the vaccine and I had not connected it before. She said that some people have had things show up on the mammogram, so they told women to delay their mammograms to a month after the vaccine because things were showing up. I wasn?t worried about it, but then my daughter and I were planning to do a trip but it was still happening. So I talked to my doctor and she did an exam in the office and she said to get a ductogram. But it takes 3 months to get in for an appointment. So I never went to get it done and went traveling because my doctor was not worried about it. But I plan to get it because I hadn?t had the chance to. It?s not every single day, but almost every single day where I have it. Liquid had continued since 2nd vaccine, even after booster. No significant changes, but continues.
8pm 3/31/2021 Fever, nausea, fatigue  4/1/2021 Extreme nausea, fever, fatigue, body aches, Heightened symptoms of neurocardiogenic syncope, easily bruising on legs 4/6/2021 Continued agitation of neurocardiogenic syncope symptoms- fainting and nausea
Feeling heart beat rapidly and regularly in chest. During fast heart beating check the heart rate, it also increases (up to 95 in rest); This is a spontaneous report from a contactable reporter (consumer or non-HCP). The reporter is the patient.   A 40-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 16Sep2021 at 18:00 (Lot number: unknown) at the age of 40 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "None" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN, Administration Time: 18:15, Anatomical Location: Right arm, Route of Administration: Unspecified), administration date: 26Aug2021, when the patient was 40 years old, for COVID-19 immunisation.  The following information was reported: HEART RATE INCREASED (non-serious) with onset 16Sep2021, outcome "not recovered", described as "Feeling heart beat rapidly and regularly in chest. During fast heart beating check the heart rate, it also increased (up to 95 in rest)". The event "Feeling heart beat rapidly and regularly in chest. During fast heart beating check the heart rate, it also increased (up to 95 in rest)" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures taken as a result of heart rate increased was unknown.  Additional Information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Racing heart rate with any movement, irregular heartbeat, and  chest pain. This lasted for a month and a half before it completely resolved. Over the course of that time the symptoms would get a little bit better after a couple of weeks, then stay at that level for a bit, then get a little better, and repeat until fully gone.
Pfizer Bivalent vaccine was administered as a primary series dose #1.  No adverse reaction.  Pt present to this reporter for a 2nd dose of primary series.  Consulted.  Per guidelines,  can proceed with monovalent Pfizer for primary series dose #2. Pt informed.
Hardness and redness around injection site; REDNESS and ITCHINESS around injection site and extending around and under arm and onto edge of chest area. Anti-itch creme helps, but the itchiness and redness is persisting.
Malaise; Headache; insomnia; This case was reported by a consumer via call center representative and described the occurrence of malaise in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th February 2022, the patient received the 1st dose of Shingrix. On 2nd March 2022, 5 days after receiving Shingrix, the patient experienced malaise, headache and insomnia. On an unknown date, the outcome of the malaise, headache and insomnia were not recovered/not resolved.   It was unknown if the reporter considered the malaise, headache and insomnia to be related to Shingrix.  Additional details were provided as follows: On 2nd March 2022, in the evening, she began to feel malaise, headache and insomnia. The patient stated that the symptoms were not resolved. The reporter did not consented to follow up.
SORENESS AND PAIN IN THE INJECTION AREA. SORENESS AND PAIN RADIATE DOWN TO ELBOW THEN UP TO SHOLDER AND UP SIDE OF NECK. MUSCLE SPASM AT TIME. PAIN NOW MAINLY IN UPPER ARM AND SHOLDER. CAN NOT LIFT ARM OVER HEAD AND WHEN I CAN THE PAIN IS SO BAD. MUSCLES HURT IN THE UPPER ARM AND SHOLDER AND SOMETIMES ON SIDE OF NECK.IT HAS BEEN ALMOST 7 MONTHS AND STILL IN PAIN
Patient received vaccine at 2:00 PM on 12/12/18 - at 2:25 PM patient experienced erythema and warmth 4 cm around injection site.
The next day "I" had muscle fatigue in arms and legs; About 2 hours after shot "I" experienced light hives on face (eyelids/lips) and palms of hands; "I" felt light headed, fuzzy immediately after the shot.; "I" felt light headed, fuzzy immediately after the shot.; Injection site pain and slight swelling for a few days which was not unnexpected.; Injection site pain and slight swelling for a few days which was not unnexpected.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 11:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The medical history included allergy to some antibiotics like penicillin and acidic foods. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. The patient previously took acetylsalicylic acid (ASPIRIN), codeine (MANUFACTURER UNKNOWN), dextromethorphan hydrobromide/doxylamine succinate/ephedrine sulfate/ethanol/paracetamol (NYQUIL) on unknown dates and experienced allergy. On 12Apr2021 at 11:30, immediately after the shot the patient felt light headed and fuzzy. The patient waited in room for 30 minutes and then in lobby for another 30 on her own. On 12Apr2021 at 13:30, about 2 hours after shot, the patient experienced light hives on face (eyelids/lips) and palms of hands. On 13Apr2021, the next day, the patient had muscle fatigue in arms and legs and on an unknown date in Apr2021 injection site pain and slight swelling for few days which was not unexpected. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events light headed, fuzzy, light hives on face (eyelids/lips) and palms of hands, muscle fatigue in arms and legs, injection site pain and slight swelling was resolved on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
That morning I had a stuffy head and thought it was allergies. Later I was having joint pain in my hip, then started feverish and not so good. I went home and tested and it was positive within 10 seconds. I called my Dr. and got PAXLOVID and started that day 9/2 for 5 days. I tested negative by the 4th day on the antiviral but the symptoms remained present like deep raspy cough that was on and off, and sinuses draining on and off (but not as bad as previous). I had diarrhea, and now have a rash all over my upper arms and back which just showed up in the last 4 days.
Child went from talking and acting normal to being non-verbal and perseverating, hyperactive, stimming.  Child is now autistic.  7/11/08 Received medical record from parent w/corrected MD contact info.  Record dated 12/1996 reveals patient w/fever, not sleeping, runny nose, irritable, left ear drainage.  Dx w/chronic left OM. Received vaccinations 12/30/1996 as well as antibiotics.  Returned 1/1997 for f/u visit & was well.  Parent called MD later that month for green nasal discharge & abdominal discomfort.  8/8/08 Reviewed medical records of 2002-2006. FINAL DX: ADHD; Asperger's  Records reveal patient experienced hyperactivity, ear tubes, walking on tip toes, hand flapping, temper tantrums, separation difficulties, difficult mental focusing, temporary speech loss @ approx 15 mos,  screaming, constipation, sleep difficulties, bedwetting, aggressive behavior, poor impulse control.  On multiple meds w/multiple med changes. 1/21/2010 Patient still has autism and all accompanying autism symptoms. There has been no relief or change of any of his symptoms.
thyroiditis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THYROIDITIS (non-serious), outcome "unknown", described as "thyroiditis".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient developed syncope after 13 minutes. Patient regained after one second. Patient was able to leave pharmacy on her own.
I felt like I was having major flu like symptoms. I had chills, cough, migraine and was very congested.  This lasted for about a week. I seen at Dr. he told me I was having a reaction to the vaccine.
* I got my vision blurry for 4 consecutive days after the vaccine.  * Really bad headaches for over a 1 week. I don't suffer of migraine or headaches in a regular basis.  * Felt like my brain got inflamed.  * My head doesn't feel the same after the vaccine.
On 10/26/22 the patient above received the Moderna Monovalent vaccine instead of the Moderna Bivalent Vaccine. He received .5 ml dose. He waited 15 minutes in our lobby without any side affects or reactions.
There was instant pain when the shot was given, it was also given a little higher on my arm than normal. My right arm was very sore and got more so as time went on. I have limited movement of my arm due to severe soreness in the muscle area.
On 5/8, I experienced a bout of Vertigo. The room was spinning, I couldn't walk steadily. After another bout of vertigo, I went to see Dr. that next week and after cleaning out my ears and removing a wax build up in the left ear, She prescribed 25 mg of Meclizine 1/2 to 1 tab up to 3 times daily. I have been taking a half of a pill once or twice daily and it seems to have helped. This is not the first time that I have experienced vertigo. My past experience was 5-8 years ago and it cleared up on it's own after around a week.
Per nursing patient states he was very ill with severe GI symptoms and bedridden for 2 weeks following flu vaccine. Symptoms: 1. Diarrhea.
Patient  started developing hives on back, arms and legs with itching from vaccine. Patient was given 50 mg of BENADRYL liquid and BENADRYL cream to apply to the itchy areas. Patient reported no difficulty breathing, throat swelling or chest heaviness. Patient was monitored for 20 more minutes and then decided to leave with daughter who was driving her. I called patient an hour later to check on her and daughter stated she was resting and feeling better now. I also reported ADR to patient's PCP.
Received routine immunizations on 01/30/2003. Returned to clinic 01/31/2003 with erythema, edema and warmth bilateral thighs. Question of cellulitis right thigh. Pt treated with Keflex x 10 days.
SECONDS AFTER RECEIVING BOTH VACCINATIONS PATIENT STARTED TO COMPLAIN OF DIZZINESS.  AFTER A FEW MINUTES HE STARTED TO SWEAT PROFUSELY AND STATED HE WAS HOT.  PT GOT VERY PALE AND PUPILS BECAME VERY DILATED.  PATIENT STATED HE COULDN'T SEE (NO SPOTS, JUST BLACKNESS).  911 WAS CALLED AND EMS DISPATCHED.  PT WAS VERY LETHARGIC, HAD TO KEEP HIM TALKING SO HE DIDN'T PASS OUT.  AFTER ~20 MINUTES PT. COLOR CAME BACK, PUPILS RETURNED TO NORMAL AND VISION WAS IMPROVING, NO LONGER COLD/CLAMMY.  EMS CHECKED PT OUT AND HE WENT HOME UNDER HIS OWN POWER.
Lymph nodes to left breast producing yellow leakage; Lymph nodes to left breast producing yellow leakage; severe pain in left breast; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration, administered on the left arm on 24Mar2021 11:15 as dose 2, single for COVID-19 immunization. Medical history included High blood pressure, brain tumor and allergies: latex. Concomitant medication included estradiol (ESTROGEN) and blood pressure medication. The patient previously received first dose of BNT162B2 on an unknown date for COVID-19 immunization. On 27Mar2021 06:00 the patient woke up with severe pain in left breast and experienced lymph nodes to left breast producing yellow leakage. The events resulted to a doctor or other healthcare professional office/clinic visit. It was unknown whether treatment was received. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the event was not recovered.  Information on the lot/batch number has been requested.
Swelling of the face; itching back; This is a spontaneous report from a contactable Other Health Professional (patient). A 89-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 18Jan2021 15:00 (at the age of 89-year-old) as dose number unknown, single for COVID-19 immunization. Medical history included Afib, Hypertension, mild allergy to dust and known allergies: detergents with sents from an unknown date and unknown if ongoing. Concomitant medication(s) included apixaban (ELIQUIS); furosemide sodium (FUROSEMIDE [FUROSEMIDE SODIUM]); metoprolol (other medications in two weeks) taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. Patient did not receive any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had been tested for COVID-19. On 18Jan2021 15:00, patient experienced swelling of the face, itching back. The patient visited doctor or other healthcare professional office/clinic for adverse events. Patient received loratadine, prednisone, triamcinolone topical cream as treatment for events. The patient underwent lab tests and procedures which included Nasal Swab: negative on 22Jan2021. Therapeutic measures were taken as a result of swelling of the face, itching back. The outcome of events was not recovered.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made.   Follow-up attempts have been completed and no further information is expected.
There was no reported adverse event but there was an administration error. Patient is less than 12 years of age and received a 3 rd dose when a 3rd dose is currently not indicated
Information has been received from a licensed practical nurse referring to a patient of unknown age and gender. On 11-JUL-2016 a dose of improperly stored M-M-R II (lot# L027591, rHA, expiration date 23-JUL-2017) was given to the patient. No adverse effects reported. The temperature excursion was 48 degree Fahrenheit for 24 hours, data logger was used. There was no prior excursion. The temperature was back in range at the time of reporting. This is one of several reports received from the same source. Additional information is not expected as there is no consent to contact the physician.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that patient didn't receive other medication in 2 weeks. The patient received Paxlovid treatment for covid-19 from 19Dec2022 to 25Dec2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
24 hours after administration became with 25 cent sized swelling, tender, red injection site. Still present at 5 day Follow up.
Fever of 102.5, redness and swelling at site of injection and full circumference of arm, warm to touch and painful at 9 on scale of 1-10.
fatigue; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (fatigue) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and Hypercholesterolemia. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for Hypercholesterolemia, ESTRADIOL (ESTROGEN) for Menopause.   On 14-Jan-2021 at 11:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). On 18-Feb-2021, FATIGUE (fatigue) and HEADACHE (headache) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-008584 (Patient Link).
Almost immediately I started having a headache that lasted for a month. It progressed to hurting as migraines do in certain parts of the brain/head area. I started taking aspirin after it was announced that the vaccines could cause blood clots. I am still experiencing the headaches although not as often. I am also experiencing joint pain and swelling. The issues that I am now dealing with are new to me.
patient received liquid component of vaccine in left arm on 8/23/23. it was discovered on 8/28/23 that patient did not receive powder. after contacting CDC advised to given patient another vaccine with both liquid and powder vials.  will follow up with patient in a couple days to see if any adverse events. patient does not currently report any side effects from liquid only injection.
Barely can walk; Pain around his penis and anus on both sides; Pain around his penis and anus on both sides; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 33-year-old male patient received BNT162b2 (BNT162B2), on 10Jun2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization.  The following information was reported: PENILE PAIN (non-serious), PROCTALGIA (non-serious) all with onset 21Jul2021, outcome "unknown" and all described as "Pain around his penis and anus on both sides"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "Barely can walk".  Additional information: The caller mentioned that he had pain around his penis and anus on both sides for almost 2 years provided after taking the second dose of the Pfizer COVID-19 vaccine. The pain started and he said he barely can walk and the pain comes back after 5 minutes of standing.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pressure in head; Body ache; Could not sleep; flu-like symptoms; sore arm; Hotness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FEELING HOT (Hotness), HEAD DISCOMFORT (Pressure in head), PAIN (Body ache) and SLEEP DISORDER (Could not sleep) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), FEELING HOT (Hotness), PAIN (Body ache), SLEEP DISORDER (Could not sleep) and INFLUENZA LIKE ILLNESS (flu-like symptoms). On an unknown date, the patient experienced HEAD DISCOMFORT (Pressure in head). On 19-Mar-2021, PAIN IN EXTREMITY (sore arm) outcome was unknown. On 21-Mar-2021, FEELING HOT (Hotness), PAIN (Body ache), SLEEP DISORDER (Could not sleep) and INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown. At the time of the report, HEAD DISCOMFORT (Pressure in head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       On 18Mar2021 patient experienced sore arm, and hotness and pressure in the head at night. Reported mentioned body aches so bad patient could not sleep. Symptoms were flu-like. Patient took paracetamol to treat symptoms   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-057960: